ADIPOQ and metabolic syndrome: The development of our models also included variables related to cardiovascular and diabetes risk that are considered in these tools; however, our main goal was to create a more robust model that incorporates new anthropometric indices, metabolic profiles, and the role of adiponectin as an indicator of its impact on the development of metabolic syndrome.